Vimarsana
Biggest News Aggregation in the World

Page 16 - Manufacturing Practice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Manufacturing Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Manufacturing Practice Today - Breaking & Trending Today

Henlius' Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer - Vimarsana News

Henlius' Serplulimab Granted Orphan-Drug Designation in the United States for Small Cell Lung Cancer

/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) announced that the United States Food and Drug Administration (FDA) has granted Orphan-Drug...

Life Sciences 2022 - Food, Drugs, Healthcare, Life Sciences - Vimarsana News

Life Sciences 2022 - Food, Drugs, Healthcare, Life Sciences

The primary legislation governing the authorisation, marketing, sale and supply of pharmaceutical products by the US Food and Drug Administration (FDA) ...

Source: mondaq.com
Transparency Market Research: Aluminum Potassium Sulfate Market to Surpass US$ 70 Mn by 2030, TMR Study - Vimarsana News

Transparency Market Research: Aluminum Potassium Sulfate Market to Surpass US$ 70 Mn by 2030, TMR Study

High demand in pharmaceutical industry to propel revenue growth during the forecast period, owing to antimicrobial activity of aluminum potassium sulfate Asia Pacific to contribute sizable opportunities

Aluminum Potassium Sulfate Market to Surpass US$ 70 Mn by 2030, TMR Study - Vimarsana News

Aluminum Potassium Sulfate Market to Surpass US$ 70 Mn by 2030, TMR Study

/PRNewswire/ -- Widespread use of aluminum potassium sulfate as a flocculant or coagulant in the purification of drinking water and wastewater treatment are...

In review: the life sciences regulatory regime in Finland - Vimarsana News

In review: the life sciences regulatory regime in Finland

This article reviews the essential regulatory considerations surrounding medicines and medical devices in Finland, including clinical trials and marketing authorisations.